Warren Buffett's company Berkshire Hathaway (BRK.A 0.59%) (BRK.B 0.53%) recently filed its latest 13F report, showing which stocks it has a position in. And by analyzing the filing, investors can see which stocks the company has been buying and selling. Berkshire hasn't been doing too much buying lately but there are a couple of stocks which it has dramatically increased its position in: Constellation Brands (STZ 0.41%) and Pool Corp (POOL 0.59%). Berkshire's share count in both of these stocks has more tha ...

TG Therapeutics (NASDAQ: TGTX ) is a commercial stage biotech company, focusing on Briumvi, a treatment for multiple sclerosis. In my prior article, initiating coverage of TGTX, I gave an overview of the company and attempted to modelLike millions of other investors, I got Robinhood and started trading during the pandemic. Unlike most of those investors, I carefully studied hundreds of earnings reports for clues to future performance, and I was able to identify many future winners, such as OPRX, OTRK, FUBO, ...

Explore the exciting world of Medpace Holdings (MEDP 1.11%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of April 23, 2025. The video was published on May 27, 2025. ...

Group 1 - Target is exploring growth opportunities through Circle 360 loyalty program and Roundel advertising revenue [1] - The company is focusing on store-as-hub logistics to enhance operational efficiency [1] - The outlook suggests that Target stock may outperform the market over the next five years [1]

Core Insights - The article presents a perspective on investment opportunities in various stocks, emphasizing the author's unique insights and background [1] Company and Industry Summary - The analyst holds a long position in Amazon (AMZN) through stock ownership, options, or other derivatives, indicating a positive outlook on the company's future performance [2] - The analysis aims to provide informational content for investors, encouraging them to conduct their own research and due diligence before making investment decisions [3]

No one can fill Warren Buffett's shoes. However, he's passing the baton as Berkshire Hathaway's CEO to a worthy successor in Greg Abel.Abel currently leads Berkshire Hathaway Energy. He also serves as vice chair of Berkshire's non-insurance operations. Come January 2026, he'll move into the CEO spot long held by Buffett. As Buffett has done for years, Abel will make the final investment decisions for Berkshire's portfolio once he becomes CEO.If you're wondering what kind of stocks Abel might like, you won't ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Rivian Automotive, Inc. RIVN is better than Lucid Group, Inc. LCID.Supporting his view, Lucid, on May 6, reported first-quarter revenue of $235.05 million, missing analyst estimates of $250 million, according to Benzinga Pro.Marvell Technology, Inc. MRVL is “right to be bought here,” Cramer said.As per the recent news, Marvell announced on Monday that it would collaborate with Nvidia Corp NVDA to offer Nvidia NVLink Fusion technology to customers employ ...

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure: I/we have a beneficial long position in the shares of NVDA, AVGO, AMZN, MRVL either through stock ownership, options, or other derivatives. I wrote ...

Core Insights - Novo Nordisk's CEO Lars Fruergaard Jørgensen is stepping down, leading to a 3.9% drop in the company's stock price [1] - The company is seeking a successor, with Jørgensen's tenure resulting in tripled sales, profits, and share price over eight years [3] - Recent growth has slowed, with sales up less than 20% and profits only increasing by 14% in the last quarter, contributing to a significant decline in stock value over the past year [3] Company Developments - The board's decision to seek new leadership is attributed to recent market challenges and the decline in share price since mid-2024 [3] - The potential for a new CEO presents an opportunity for investors to purchase Novo Nordisk stock at a lower price, with the stock currently priced under 19 times earnings [4] - The company’s sales growth remains strong at nearly 20%, indicating potential for recovery under new leadership [4]